Interstitial Cystitis (IC) is a painful bladder syndrome in which inflamed and irritated bladder cause recurring discomfort or pain. The symptoms of IC include an urgent or frequent need to urinate and pain during bladder filling. Women are more prone to develop this condition. Pain may be mild or so severe as to be debilitating and it can vary from day to day. IC is categorized into non-ulcerative and ulcerative. Non-ulcerative IC is the most common condition found in 90% of IC patients. It causes pinpoint hemorrhages in the bladder wall. Ulcerative form of IC patients comprises 5% to 10% of IC that usually have red Hunner’s ulcers or patches on the bladder wall. The exact cause of IC is unknown. Urinary tract infection due to bacteria and bladder overextension can trigger the painful condition in IC. Nerve injuries in the surrounding area of bladder or spinal cord can also cause IC.
There are many treatment options available to relieve the bladder pain symptoms, urgency, and frequency. In combination therapy, heparinoid drugs along with other oral medications help to restore integrity of the bladder lining. The symptomatic treatment includes over-the-counter medicines, topical medicines and narcotic pain medicines. Regular exercise, acupuncture, healthy diet and self-management are some of the non-pharmacological treatment used to control symptoms of IC.
There are more than 20 drugs present in the IC pipeline. In pipeline analysis, drugs are analyzed based on route of administration, and molecule type. The pipeline is also analyzed based on monotherapy and combination therapy, and different clinical phases including Phase III, Phase II, Phase I and Pre-Clinical stage.
Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/interstitial-cystitis-disease-pipeline-analysis/toc-sample
Pipeline analysis provides description about the key companies which are developing drugs for IC. Some of the key players actively involved in the research and development are Lipella Pharmaceuticals, Inc., Mundipharma Research GmbH & Co KG, Urigen Pharmaceuticals Inc., Astellas Pharma, Inc. and MediciNova, Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)